Chinese Producer Of Abortion Pill Under Investigation

Law360, New York (January 31, 2008, 12:00 AM EST) -- A Chinese pharmaceutical giant is being questioned over the safety of controversial abortion pill RU-486, which it supplies to the United States, after the contamination of a different drug injured scores of cancer patients in China.

An estimated 200 Chinese cancer patients developed serious side effects, including paralysis, after using a tainted leukemia drug. The drugs were produced by manufacturer Shanghai Hualian, a subsidiary of Shanghai Pharmaceutical Group.

Chinese drug regulators have accused the pharmaceutical company of trying to cover up the contamination, which prompted the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.